The estimated Net Worth of Jeff Eidel is at least $1.87 million dollars as of 19 August 2024. Jeff Eidel owns over 26,760 units of Pacific Biosciences of California Inc stock worth over $1,461,146 and over the last 2 years Jeff sold PACB stock worth over $409,838.
Jeff has made over 3 trades of the Pacific Biosciences of California Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Jeff sold 26,760 units of PACB stock worth $42,548 on 19 August 2024.
The largest trade Jeff's ever made was selling 26,760 units of Pacific Biosciences of California Inc stock on 19 August 2024 worth over $42,548. On average, Jeff trades about 11,366 units every 61 days since 2022. As of 19 August 2024 Jeff still owns at least 869,730 units of Pacific Biosciences of California Inc stock.
You can see the complete history of Jeff Eidel stock trades at the bottom of the page.
Jeff's mailing address filed with the SEC is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025.
Over the last 14 years, insiders at Pacific Biosciences of California Inc have traded over $95,441,111 worth of Pacific Biosciences of California Inc stock and bought 2,252,330 units worth $6,097,136 . The most active insiders traders include Michael Hunkapiller, John F Milligan et Christian O Henry. On average, Pacific Biosciences of California Inc executives and independent directors trade stock every 44 days with the average trade being worth of $202,112. The most recent stock trade was executed by Jeff Eidel on 19 August 2024, trading 26,760 units of PACB stock currently worth $42,548.
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
Pacific Biosciences of California Inc executives and other stock owners filed with the SEC include: